Ocugen (OCGN) Notes Payables (2015 - 2021)

Ocugen (OCGN) posted Notes Payables of $374000.0 for Q1 2021, up 59.83% on a QoQ basis from $234000.0 in Q4 2020.

Ocugen (OCGN) Notes Payables (2015 - 2021) Analysis & Trends

Ocugen's Notes Payables history runs 6 years deep, the most recent figure standing at $374000.0 for Q1 2021.

Quarterly Notes Payables changed N/A year-over-year to $374000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $374000.0 (changed N/A YoY) and the FY2020 annual result came in at $234000.0, changed N/A from the prior year.
Notes Payables was $374000.0 for Q1 2021 at Ocugen, up from $234000.0 in the prior quarter.
Across five years, Notes Payables topped out at $7.5 million in Q4 2018 and bottomed at $234000.0 in Q4 2020.
A 4-year average of $3.0 million and a median of $2.6 million in 2020 frame the typical range for Notes Payables.
Peak annual rise in Notes Payables reached 6.94% in 2020, while the deepest fall reached 6.94% in 2020.
Ocugen's Notes Payables stood at $7.5 million in 2018, then plunged by 41.59% to $4.4 million in 2019, then plunged by 94.65% to $234000.0 in 2020, then jumped by 59.83% to $374000.0 in 2021.
Business Quant data shows OCGN's Notes Payables at $374000.0 in Q1 2021, $234000.0 in Q4 2020, and $1.2 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ocugen	63.79 Mn	63.79 Mn	-

Download Data